Dan Leonard
Stock Analyst at UBS
(2.04)
# 2,711
Out of 4,814 analysts
278
Total ratings
54.61%
Success rate
-6.36%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Neutral | $20 → $14 | $7.51 | +86.42% | 4 | Feb 13, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $260 → $255 | $143.91 | +77.19% | 13 | Feb 7, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $700 → $715 | $436.79 | +63.69% | 14 | Jan 31, 2025 | |
| AVTR Avantor | Downgrades: Neutral | $29 → $25 | $15.40 | +62.34% | 7 | Jan 17, 2025 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | $250 → $185 | $105.93 | +74.64% | 6 | Jan 17, 2025 | |
| BRKR Bruker | Assumes: Neutral | $102 → $66 | $37.74 | +74.88% | 10 | Dec 10, 2024 | |
| DHR Danaher | Maintains: Buy | $309 → $305 | $190.66 | +59.97% | 16 | Oct 23, 2024 | |
| CYRX Cryoport | Maintains: Neutral | $7 → $9 | $5.55 | +62.16% | 2 | Oct 18, 2024 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $420 → $350 | $296.28 | +18.13% | 1 | Sep 27, 2024 | |
| CERT Certara | Upgrades: Buy | $16 | $14.15 | +13.07% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $45.18 | -11.47% | 8 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $420 → $385 | $238.22 | +61.62% | 19 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $420 → $385 | $225.29 | +70.89% | 19 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $105 → $125 | $95.54 | +30.84% | 1 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $51.07 | +56.65% | 10 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $17.86 | +96.02% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $102.47 | +46.38% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $71.16 | +181.06% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $1.78 | +519.72% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $148.08 | -52.73% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $90 | $41.59 | +116.42% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $7.33 | -4.44% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $321.12 | +7.44% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $139.30 | +86.65% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $163.77 | -11.46% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $57.55 | +56.39% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $40.72 | +56.31% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $217.06 | +56.64% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $22.03 | +8.94% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1,350 → $1,500 | $1,014.38 | +47.87% | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $7.63 | +358.72% | 12 | Aug 14, 2019 |
10x Genomics
Feb 13, 2025
Maintains: Neutral
Price Target: $20 → $14
Current: $7.51
Upside: +86.42%
IQVIA Holdings
Feb 7, 2025
Maintains: Buy
Price Target: $260 → $255
Current: $143.91
Upside: +77.19%
Thermo Fisher Scientific
Jan 31, 2025
Maintains: Buy
Price Target: $700 → $715
Current: $436.79
Upside: +63.69%
Avantor
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $15.40
Upside: +62.34%
Charles River Laboratories International
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $105.93
Upside: +74.64%
Bruker
Dec 10, 2024
Assumes: Neutral
Price Target: $102 → $66
Current: $37.74
Upside: +74.88%
Danaher
Oct 23, 2024
Maintains: Buy
Price Target: $309 → $305
Current: $190.66
Upside: +59.97%
Cryoport
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $5.55
Upside: +62.16%
Medpace Holdings
Sep 27, 2024
Downgrades: Neutral
Price Target: $420 → $350
Current: $296.28
Upside: +18.13%
Certara
Sep 27, 2024
Upgrades: Buy
Price Target: $16
Current: $14.15
Upside: +13.07%
Aug 21, 2024
Maintains: Buy
Price Target: $32 → $40
Current: $45.18
Upside: -11.47%
May 8, 2024
Maintains: Buy
Price Target: $420 → $385
Current: $238.22
Upside: +61.62%
May 8, 2024
Maintains: Buy
Price Target: $420 → $385
Current: $225.29
Upside: +70.89%
Jan 16, 2024
Downgrades: Neutral
Price Target: $105 → $125
Current: $95.54
Upside: +30.84%
Dec 7, 2023
Initiates: Buy
Price Target: $80
Current: $51.07
Upside: +56.65%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $17.86
Upside: +96.02%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $102.47
Upside: +46.38%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $71.16
Upside: +181.06%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $1.78
Upside: +519.72%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $148.08
Upside: -52.73%
Aug 2, 2023
Maintains: Neutral
Price Target: $75 → $90
Current: $41.59
Upside: +116.42%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $7.33
Upside: -4.44%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $321.12
Upside: +7.44%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $139.30
Upside: +86.65%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $163.77
Upside: -11.46%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $57.55
Upside: +56.39%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $40.72
Upside: +56.31%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $217.06
Upside: +56.64%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $22.03
Upside: +8.94%
Jul 30, 2021
Maintains: Equal-Weight
Price Target: $1,350 → $1,500
Current: $1,014.38
Upside: +47.87%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $7.63
Upside: +358.72%